Harbour Investments’s CRISPR Therapeutics CRSP Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $62K | Sell |
1,275
-136
| -10% | -$6.62K | ﹤0.01% | 1712 |
|
|
2025
Q1 | $48K | Sell |
1,411
-306
| -18% | -$10.4K | ﹤0.01% | 1791 |
|
|
2024
Q4 | $67.6K | Sell |
1,717
-350
| -17% | -$13.8K | ﹤0.01% | 1569 |
|
|
2024
Q3 | $97.1K | Sell |
2,067
-139
| -6% | -$6.53K | ﹤0.01% | 1330 |
|
|
2024
Q2 | $119K | Buy |
2,206
+389
| +21% | +$21K | ﹤0.01% | 1163 |
|
|
2024
Q1 | $124K | Buy |
1,817
+236
| +15% | +$16.1K | ﹤0.01% | 1114 |
|
|
2023
Q4 | $99K | Sell |
1,581
-114
| -7% | -$7.14K | ﹤0.01% | 1141 |
|
|
2023
Q3 | $76.9K | Buy |
1,695
+4
| +0.2% | +$182 | ﹤0.01% | 1146 |
|
|
2023
Q2 | $94.9K | Buy |
1,691
+60
| +4% | +$3.37K | ﹤0.01% | 1083 |
|
|
2023
Q1 | $73.8K | Hold |
1,631
| – | – | ﹤0.01% | 1182 |
|
|
2022
Q4 | $66.3K | Sell |
1,631
-61
| -4% | -$2.48K | ﹤0.01% | 1186 |
|
|
2022
Q3 | $103K | Hold |
1,692
| – | – | 0.01% | 949 |
|
|
2022
Q2 | $103K | Buy |
+1,692
| New | +$103K | 0.01% | 949 |
|
|
2021
Q4 | $113K | Buy |
1,491
+952
| +177% | +$72.2K | 0.01% | 922 |
|
|
2021
Q3 | $60K | Buy |
539
+54
| +11% | +$6.01K | ﹤0.01% | 1658 |
|
|
2021
Q2 | $79K | Sell |
485
-39
| -7% | -$6.35K | ﹤0.01% | 1526 |
|
|
2021
Q1 | $64K | Buy |
+524
| New | +$64K | ﹤0.01% | 1530 |
|